MedTrace Logo

Very Small Embryonic-like Stem Cells for Facial Skin Antiaging

NCT03976206 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2020-10-19

No results posted yet for this study

Summary

The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to facial skin antiaging.

Conditions

  • Stem Cell Transplant Complications
  • Skin Inflammation

Interventions

BIOLOGICAL

Very small embryonic-like stem cell

We carried out the subdermal application of VSELs with a 1-mL syringe (volume, 0.4 mL) coupled to a 30-gauge needle, in the left preauricular area (1-cm2 area), 2 cm distal from the tragus

Sponsors & Collaborators

  • Guangzhou Four-Leaf Clover HealthTech Co., Ltd.

    collaborator INDUSTRY

  • Fuda Cancer Hospital, Guangzhou

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-06
Primary Completion
2020-05-20
Completion
2020-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03976206 on ClinicalTrials.gov